|
2.4 Etiologie - Portables, ondes e-m
|
|
|
|
2.7 Etiologie - Obésité
|
|
|
|
|
3.6 Prévention - Activité physique
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
5. Traitements
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
|
5.2 Pharma
|
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
EU drugmakers urge June decision on new location for watchdog [Reuters]
|
|
|
|
|
|
"Were
a rapid resolution on the future location of the EMA not to
materialize, or if the future seat of the European Medicines Agency were
to fail in terms of establishing its minimum prerequisites, the quality
of its work and the future of the European Medicines Regulatory Network
would be placed in jeopardy."
|
|
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
|
Pending EC decision: Avastin, bevacizumab, Opinion date: 21-Apr-2017 [EMA]
|
|
|
|
|
|
The
CHMP adopted an extension to an existing indication as follows:
"Bevacizumab, in combination with carboplatin and gemcitabine or in
combination with carboplatin and paclitaxel, is indicated for treatment
of adult patients with first recurrence of platinum-sensitive epithelial
ovarian, fallopian tube or primary peritoneal cancer who have not
received prior therapy with bevacizumab or other VEGF inhibitors or VEGF
receptor–targeted agents".
|
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
5.6 ESMO
|
|
|
ELCC 2017 Media Alert: European Lung Cancer Conference Preview [ESMO]
|
|
|
|
|
|
The
European Lung Cancer Conference is a collaborative effort of the most
important multidisciplinary societies representing thoracic oncology
specialists, all working towards a shared goal: to advance science,
disseminate education and improve the practice of lung cancer
specialists worldwide.
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.12 Ethique
|
|
|
|
Should You Worry About Being the Next Henrietta Lacks? [NY Times]
|
|
|
|
|
|
Researchers
have produced over 20 tons of those cells — called “HeLa cells” after
her name — facilitating the development of new drugs and vaccines,
aiding many millions of patients and earning biotech and pharmaceutical
companies hundreds of millions of dollars in profits.
|
|
|
|
|
|